NCT06125249|Unknown
Loading search results
Sponsor study identifier
observational
60
1 country
1
Study Start
July 1, 2022
Actual (reported)Primary Completion
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The goal of this observational study is to explore the value of Humanin for early diagnosis and short-term prognosis of AKI patients after heart transplantation. The main question it aims to answer are:whether Humanin can be a novel marker for predicting AKI after heart transplantation Researchers will compare the Humanin concentration in patients with AKI did not occur after heart transplantation to see if Humanin can be a novel marker for predicting AKI after heart transplantation
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1, 2022
Actual (reported)November 5, 2023
Actual (reported)November 9, 2023
Actual (reported)June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Humanin concentration
Highest measured value used
3 months
Serum creatinine concentration
Meets KDIGO's definition of AKI
3 months
AKI occurs in patients after heart transplantation
Patients who do not develop AKI after heart transplantation
Heart transplant patients from Guangdong Provincial People's Hospital from September 2022 to May 2024
Guangdong Provincial People's Hospital
Guangdong, Guangzhou, 510000, China
zhilian PP li, doctor
Guangdong Provincial People's Hospital
First Submitted
November 5, 2023
First Posted
November 9, 2023
Study Start
July 1, 2022
Actual (reported)Primary Completion
June 2024
Estimated (date passed)Dynamic Change of Doppler-based Renal Resistive Index in Predicting Renal Recovery
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 9, 2023
Record last verified: 2023-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: